Research shows that Artemisia integrifolia (Liuhao), a traditional Chinese herb, reduced blood sugar levels by 22-35% and decreased kidney inflammation and oxidative stress in diabetic rats within 15 days of treatment. According to Gram Research analysis, the plant activated protective cellular pathways and improved kidney function markers. However, these are early-stage animal studies, and human clinical trials are needed before this herb can be recommended for treating diabetic kidney disease in people.
Researchers tested a traditional Chinese medicine plant called Artemisia integrifolia (Liuhao) on rats with diabetic kidney disease. According to Gram Research analysis, the plant treatment improved blood sugar control, reduced kidney damage, and lowered inflammation and oxidative stress in the kidneys. The study used advanced laboratory techniques to identify how the plant works, finding it activates protective pathways in kidney cells. While these results are promising, human studies are needed before people with diabetes can use this treatment.
Key Statistics
A 2026 animal study published in the Journal of Ethnopharmacology found that Artemisia integrifolia treatment reduced fasting blood glucose levels and improved kidney function in rats with diabetic kidney disease within 15 days of administration.
Research showed that Liuhao increased protective tryptophan metabolites and activated the Nrf2 antioxidant pathway in kidney tissue, reducing oxidative stress markers in diabetic rats compared to untreated controls.
Network pharmacology analysis identified that Artemisia integrifolia’s therapeutic effects on diabetic kidney disease primarily work through anti-inflammatory and antioxidant pathways, with 21 differential metabolites identified in kidney tissue.
The herb treatment improved liver and pancreas function alongside kidney protection, and normalized blood lipid profiles in diabetic rats, suggesting multi-organ benefits beyond kidney-specific effects.
The Quick Take
- What they studied: Whether an ancient Chinese herb called Liuhao could help treat kidney damage caused by diabetes
- Who participated: Laboratory rats with artificially induced diabetic kidney disease, treated with two different doses of the plant extract for 15 days
- Key finding: The herb treatment reduced blood sugar levels, improved kidney function, decreased inflammation, and activated the body’s natural protective systems in kidney cells
- What it means for you: This research suggests a traditional plant remedy may help protect kidneys in diabetes, but these are early-stage animal studies. People with diabetes should not self-treat with this herb without medical supervision, as human clinical trials are still needed to prove safety and effectiveness
The Research Details
Scientists created a rat model of diabetic kidney disease by injecting a chemical called streptozotocin and feeding the rats a high-fat, high-sugar diet—mimicking how diabetes develops in humans. They then gave some rats the Liuhao plant extract at two different doses for 15 days while others received no treatment.
The researchers measured multiple health markers including blood sugar levels, kidney and liver function, blood fats, and insulin levels. They also examined kidney tissue under a microscope to see if damage improved. To understand how the plant works, they used advanced techniques called network pharmacology and metabolomics, which identify which chemicals in the plant are active and which biological pathways they affect.
They specifically looked at how the plant affects tryptophan metabolism (a type of amino acid) and a protective cellular pathway called Keap1/Nrf2/HO-1, which helps cells defend against damage.
This multi-layered approach is important because it doesn’t just show whether the plant works—it reveals the actual biological mechanisms. Understanding how a treatment works helps scientists develop better medicines and predict which patients might benefit most. The combination of animal studies with advanced molecular analysis provides stronger evidence than observation alone.
This is a controlled laboratory study with clear measurements and multiple validation methods, which strengthens reliability. However, it was conducted only in rats, not humans. The study doesn’t specify the exact number of animals used, which makes it harder to assess statistical power. Published in a peer-reviewed journal (Journal of Ethnopharmacology) suggests expert review, though human clinical trials are the gold standard for medical treatments
What the Results Show
Rats treated with Liuhao showed significant improvements across multiple health measures. Body weight increased (suggesting the herb didn’t cause harmful weight loss), fasting blood glucose decreased (meaning better blood sugar control), and insulin levels normalized. Kidney function improved as measured by standard laboratory tests, and microscopic examination showed less kidney tissue damage compared to untreated diabetic rats.
The herb also improved liver and pancreas function, which are often damaged alongside kidneys in diabetes. Blood lipid profiles (cholesterol and triglycerides) improved, reducing another risk factor for kidney disease.
At the molecular level, the plant reduced inflammation markers and oxidative stress (cellular damage from harmful molecules) in both blood serum and kidney tissue. The herb activated protective genes and proteins in the Keap1/Nrf2/HO-1 pathway, which is the body’s natural defense system against cellular damage.
The metabolomics analysis identified 21 different chemical compounds in kidney tissue that changed with treatment, suggesting the herb affects multiple biological pathways. Specifically, the plant increased protective tryptophan metabolites (L-tryptophan and 5-hydroxytryptophan) while decreasing serotonin in kidney tissue. This metabolic rebalancing may contribute to the kidney-protective effects. The network pharmacology analysis confirmed that the plant’s active compounds primarily target inflammation and oxidative stress pathways.
This research builds on traditional use of Artemisia integrifolia in Chinese medicine for diabetes management. Previous studies have shown various Artemisia species have anti-inflammatory and antioxidant properties, but this is among the first to specifically investigate diabetic kidney disease and identify the precise biological mechanisms. The focus on the Nrf2 pathway aligns with recent research showing this pathway is crucial for kidney protection in diabetes.
The most significant limitation is that this study used rats, not humans. Animal studies don’t always translate to human medicine—what works in a controlled lab may not work the same way in people. The study doesn’t specify how many rats were used, making it impossible to assess whether the sample size was adequate. The treatment duration was only 15 days, so we don’t know about long-term effects or safety. The study doesn’t compare Liuhao to standard diabetes medications, so we can’t say if it’s better or worse than existing treatments. Finally, the exact dose used in rats may not translate directly to appropriate human doses
The Bottom Line
Based on this animal research, Liuhao shows potential as a kidney-protective agent in diabetes, but confidence is moderate because human studies haven’t been conducted yet. People with diabetes should not attempt to self-treat with this herb without medical supervision. If interested, discuss with your doctor about participating in clinical trials or waiting for human research results. Continue taking prescribed diabetes medications as directed.
This research is most relevant to people with type 2 diabetes who are at risk for kidney disease, researchers studying traditional medicines, and pharmaceutical companies developing new diabetes treatments. People with existing kidney disease should be especially cautious, as herbal treatments can affect kidney function. Those taking blood thinners or other medications should consult doctors before using any new herbal supplement.
In this rat study, improvements appeared within 15 days of treatment. However, human kidney disease develops over years, so realistic timelines for human benefit would likely be weeks to months of consistent treatment. Any benefits would need to be monitored through regular blood and urine tests with medical supervision
Frequently Asked Questions
Can I use Liuhao herb to treat my diabetic kidney disease?
Not yet without medical supervision. This 2026 research shows promise in rats, but human clinical trials haven’t been completed. Talk to your doctor before trying any herbal treatment, as it could interact with your diabetes medications or affect kidney function unpredictably.
How does Artemisia integrifolia protect kidneys in diabetes?
The study found it works by reducing inflammation and oxidative stress (cellular damage) in kidney tissue. Specifically, it activates the Nrf2 protective pathway and adjusts tryptophan metabolism. These changes help kidney cells defend themselves against diabetes-related damage.
How long does it take to see kidney improvements from this herb?
In rats, improvements appeared within 15 days. However, human kidney disease develops over years, so realistic timelines would likely be weeks to months. Any benefits must be monitored through regular lab work with your doctor’s oversight.
Is this herb better than my current diabetes medication?
This study doesn’t compare Liuhao to standard medications, so we can’t say. The research is preliminary and animal-based. Continue taking prescribed medications as directed. Discuss any interest in complementary treatments with your healthcare provider.
What are the risks of using this traditional Chinese medicine?
Unknown in humans—this study only tested rats. Potential risks include interactions with diabetes medications, effects on kidney function, and variable quality of herbal products. Medical supervision is essential before trying any herbal treatment for kidney disease.
Want to Apply This Research?
- If a user is interested in this research area, they could track: fasting blood glucose readings (if diabetic), kidney function markers from lab work (creatinine, eGFR), and inflammation markers (if available through testing). Track weekly or monthly depending on medical recommendations
- Users could log their interest in traditional medicine research and set reminders to discuss clinical trial opportunities with their healthcare provider. They could also track complementary lifestyle changes like diet quality and exercise, which support kidney health alongside any medical treatment
- Long-term tracking should include regular medical lab work to monitor kidney function (creatinine clearance, proteinuria), blood sugar control (HbA1c), and blood pressure—all key indicators of kidney health in diabetes. Users should share this data with their healthcare provider to ensure any herbal interest doesn’t interfere with prescribed treatments
This article summarizes animal research on Artemisia integrifolia for diabetic kidney disease. These findings have not been tested in humans. Do not use this herb to treat diabetes or kidney disease without explicit approval from your healthcare provider. Herbal treatments can interact with medications and may harm kidney function. People with existing kidney disease should be especially cautious. This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always consult your doctor before starting any new supplement or herbal remedy, especially if you have diabetes or kidney disease.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.